How Emily Found ORILISSA

[LOGO]

[Text on Screen]
What is ORILISSA?
ORILISSA is a prescription medicine used to treat moderate to severe pain associated with endometriosis. It is not known if ORILISSA is safe and effective in children.

Individual results may vary.

[Text on Screen]
EMILY S.
CALIFORNIA

[Text on Screen]
Do not take ORILISSA if you:
Are pregnant, have osteoporosis, have severe liver disease, are taking medicines called OATP 1B1 inhibitors that are known or expected to significantly increase the blood levels of elagolix, the active ingredient in ORILISSA (ask your HCP if you are not sure if you are taking one of these medicines), or have had a serious allergic reaction to ORILISSA or any of the ingredients in ORILISSA. See the end of the Medication Guide for a complete list of ingredients in ORILISSA. Ask your HCP if you are not sure.

Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

Emily:
I did not think ORILISSA would work….

[Text on Screen]
I DIDN’T DARE BELIEVE

Emily:
...because I didn't dare believe that it could.

[Text on Screen]
MY DOCTOR RECOMMENDED THAT I TRY IT

Emily:
My doctor recommended that I try it.

Emily:
He was insistent that…

[Text on Screen]
IT REALLY COULD HELP ME

Emily:
…it really could help me.

Emily:
I was really scared to get my hopes up…

Emily:
…but I thought to myself, like…

Emily:
…if there’s something that could help you…

[Text on Screen]
WOULDN’T YOU WANT TO TRY IT?

Emily:
…wouldn’t you want to try it?

[Text on Screen]
Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

Emily:
Wouldn’t you want to see if it could work for you?

[Text on Screen]
Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

Emily:
I really felt like I owed it to myself…

[Text on Screen]
I DECIDED TO TRY ORILISSA® (elagolix)

Emily:
…so that’s why I decided to try ORILISSA.

[Text on Screen]
I DOVE RIGHT IN

Emily:
I dove right in…

[Text on Screen]
SURE ENOUGH IT’S WORKING

Emily:
…and sure enough, it’s working.

[Text on Screen]
JUST LESS PAIN

Emily:
Now, there’s just less pain…

Emily:
…which is amazing.

[Text on Screen]
BEFORE STARTING

Emily:
Before starting ORILISSA…

[Text on Screen]
DIDN’T BELIEVE

Emily:
…I just didn’t believe there was…

Emily:
…a treatment…

Emily:
…for my endometriosis pain.

Emily:
If you’re in that position…

Emily:
….where you feel hopeless…

[Text on Screen]
DON’T GIVE UP

Emily:
…don’t give up.

[Text on Screen]
THIS COULD WORK

Emily:
This could work.

Emily:
I tried ORILISSA and now…

[Text on Screen]
I’M A BELIEVER

Emily:
…I’m a believer.

[Text on Screen]
THINKING ABOUT TRYING ORILISSA (elagolix)?

[Text on Screen]
TALK TO YOUR GYNECOLOGIST TO SEE IF IT COULD BE RIGHT FOR YOU.

[ORILISSA logo]

[Text on Screen/Voiceover]
SAFETY CONSIDERATIONS

Do not use ORILISSA if you are pregnant, have osteoporosis or severe liver disease, take medicines called organic anion transporting polypeptide (OATP) 1B1 inhibitors that are known or expected to significantly increase the blood levels of elagolix (the active ingredient in ORILISSA), or have had a serious allergic reaction to ORILISSA or any of the ingredients in ORILISSA. ORILISSA does not prevent pregnancy. It may alter your period, so watch for other signs of pregnancy. Stop taking ORILISSA if you become pregnant. Ask about proper birth control, as some may affect how ORILISSA works. ORILISSA may affect how some birth control works. ORILISSA can cause serious side effects, including bone loss, abnormal liver tests, suicidal thoughts or behaviors, and worsening mood. Talk to your healthcare provider right away if you notice changes such as jaundice, dark amber-colored urine, suicidal thoughts or actions, depression, or worsening mood.

Please see additional Important Safety Information and the Full Prescribing Information, including Medication Guide, on this website.

US-ORIL-210027